AB1904Am15, a novel anti-IgE antibody, might have the potential in treating the asthma patients with COPD overlap syndrome and cardiovascular diseases, and protecting the patients with severe COVID-19 and leading to greater survival. The gene discussed is IGHE; the disease is overlapping connective tissue disease.